Clinical Trial Update: Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial comparing oral versus injectable risperidone for first-episode schizophrenia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2020-03-23